Allogeneic Chondrocyte Membrane Implant for Cartilage Defects
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic interventions for chondral and osteochondral lesions, such as focal lesions in the load-bearing region of a knee's articular cartilage, often fail to address the origin of the lesion and do not prevent progressive cartilage degradation, with existing treatments like total knee replacements having limited lifespan and autologous chondrocyte implantation requiring multiple invasive procedures.
Innovation Solution
A composition comprising cultured allogeneic chondrocytes seeded on a resorbable collagen membrane at a density of at least 250,000 cells per cm², derived from a cryogenically frozen cell bank, is used to treat chondral and osteochondral defects, reducing the need for multiple invasive procedures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If autologous chondrocyte implantation is used to treat cartilage lesions, then cartilage regeneration is achieved, but multiple invasive procedures are required
Solution Approach 1:
Chondrocytes are harvested and expanded in cell culture beforehand, and allogeneic cells are prepared from a cryogenically frozen cell bank in advance. This preliminary preparation allows the cells to be ready for implantation without requiring a separate harvesting procedure at the time of treatment, thereby reducing the number of invasive procedures needed.
Solution Approach 2:
Allogeneic chondrocytes from a cell bank serve as a substitute (copy) for autologous chondrocytes. These donor cells can be expanded and prepared in advance, eliminating the need for the patient to undergo multiple invasive harvesting and implantation procedures while still providing effective cartilage regeneration.
2Reliability
If total knee replacement is performed to treat severe cartilage degradation, then symptom relief is achieved, but the prosthesis has limited lifespan
Solution Approach 1:
The implanted allogeneic chondrocytes serve themselves by differentiating and producing native cartilage matrix. This self-service mechanism allows the cells to regenerate functional cartilage tissue that integrates with the patient's existing cartilage, providing a biologically sustainable solution rather than a mechanical prosthesis with limited lifespan.
Solution Approach 2:
The treatment changes the biological parameters of the joint by introducing living cells that can proliferate, differentiate, and produce extracellular matrix. This transforms the joint from a mechanically degraded state to a biologically active regeneration process, potentially providing long-term durability beyond what mechanical prostheses can offer.
3Ease of operation
If current therapeutic interventions remove damaged cartilage to provide temporary symptom relief, then short-term symptom management is achieved, but the origin of the lesion is not treated and progressive degradation continues
Solution Approach 1:
Instead of simply removing damaged cartilage, the invention uses the implantation site as a beneficial target for regenerative therapy. The allogeneic chondrocytes are implanted directly into the lesion, converting the harmful defect into a site of active regeneration where new cartilage is formed, thereby addressing both symptom relief and the underlying cause.
Solution Approach 2:
The allogeneic chondrocytes are prepared and expanded in advance before implantation. This preliminary action ensures that a sufficient number of viable cells are available to effectively repopulate and regenerate the cartilage defect, providing both immediate coverage and long-term protective function.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides effective treatment of cartilage lesions with a single invasive procedure, promoting cartilage regeneration and preventing progressive degradation, offering a more efficient alternative to existing methods.
Implementation Method 1
a resorbable collagen membrane, wherein cells are seeded on the membrane at a density of at least 250,000 cells per cm2
Implementation Method 2
cultured allogeneic cells grown from a cryogenically frozen cell bank sample
Data Source
AI summary
The present disclosure provides compositions and methods for repairing cartilage defects.

